Provenance du réseau au premier degré de Jamie Webb
Entité | Type d'entité | Industrie | |
---|---|---|---|
10
| Public Company | Pharmaceuticals: Major | 10 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jamie Webb via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
SURMODICS, INC. | Medical Specialties | Corporate Officer/Principal | |
Thomas Jefferson University | College/University | Doctorate Degree | |
OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
Wayne State University (Michigan) | College/University | Undergraduate Degree | |
Vanderbilt University | College/University | Graduate Degree | |
NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Part of Amplifon SpA, Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ is an American company that manufactures and markets hearing aids and related products. Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business was acquired by Amplifon SpA from Bausch & Lomb, Inc. on August 30, 1999. | Medical Specialties | Corporate Officer/Principal | |
Bucknell University | College/University | Undergraduate Degree | |
Central Connecticut State University | College/University | Undergraduate Degree | |
University of Detroit Mercy | College/University | Graduate Degree | |
University of Hartford | College/University | Masters Business Admin | |
University of Michigan | College/University | Doctorate Degree Doctorate Degree | |
OXURION NV | Pharmaceuticals: Major | Director/Board Member | |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Medical Specialties | Chief Executive Officer General Counsel | |
Pan-American Ophthalmological Foundation | Director/Board Member | ||
IVERIC BIO, INC. | Pharmaceuticals: Generic | Chairman | |
Fortera Federal Credit Union
Fortera Federal Credit Union Savings BanksFinance Fortera Federal Credit Union engages in the provision of financial services. It offers personal and business checking and savings accounts, loans, and other banking services. The company was founded in 1954 and is headquartered in Clarksville, TN. | Savings Banks | Corporate Officer/Principal | |
Ingram Content Group LLC
Ingram Content Group LLC Publishing: Books/MagazinesConsumer Services Ingram Content Group LLC publishes and distributes books. It offers solutions that include physical book distribution, print-on-demand, and digital services. The company was founded in 1964 and is headquartered in La Vergne, TN. | Publishing: Books/Magazines | Corporate Officer/Principal | |
Implandata Ophthalmic Products GmbH
Implandata Ophthalmic Products GmbH Electronic Equipment/InstrumentsElectronic Technology Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany. | Electronic Equipment/Instruments | Director/Board Member | |
Encore Vision, Inc.
Encore Vision, Inc. Medical/Nursing ServicesHealth Services Encore Vision, Inc. operates as an ophthalmology clinic. It offers EV06, an ophthalmic pharmaceutical solution in a conventional eye drop bottle, which includes its proprietary active pharmaceutical ingredient (API). The company is headquartered in Spokane, WA. | Medical/Nursing Services | Director/Board Member | |
American Society of Cataract & Refractive Surgery Foundation | Director/Board Member | ||
CELCUITY INC. | Medical Specialties | General Counsel | |
Himalayan Cataract Project | Director/Board Member | ||
Envisia Therapeutics, Inc.
Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Director/Board Member | |
EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Park Compounding, Inc.
Park Compounding, Inc. Drugstore ChainsRetail Trade Part of Harrow, Inc., Park Compounding, Inc. is a company that operates pharmacies and drug stores. The company is based in San Diego, CA. The company was founded by Dennis E. Saadeh. | Drugstore Chains | Founder | |
ETON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
EXICURE, INC. | Biotechnology | General Counsel | |
GREENBROOK TMS INC. | Medical/Nursing Services | Director/Board Member | |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Biotechnology | Founder Director/Board Member Founder Director/Board Member | |
Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Melt Pharmaceuticals, Inc. engages in the development and commercialization of proprietary non-opioid, non-intravenous, or non-IV, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. It intends to seek regulatory approval through the FDA regulatory pathway for the proprietary, patented small-molecule product candidates. The company was founded by Mark L. Baum on April 3, 2018 and is headquartered in Brentwood, TN. | Pharmaceuticals: Major | Director/Board Member Founder | |
Retinal Degeneration Fund | Chairman | ||
Radley Pharmaceuticals, Inc.
Radley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Harrow, Inc., Radley Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Carson, NV. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ImprimisRx LLC | Chief Executive Officer | ||
Qlaris Bio, Inc.
Qlaris Bio, Inc. BiotechnologyHealth Technology Qlaris Bio, Inc. operates as a biotechnology company. The company was founded by Thurein Htoo and Barbara Wirostko and is headquartered in Wellesley, MA. | Biotechnology | Director/Board Member | |
TherOptix, Inc.
TherOptix, Inc. Electronic ComponentsElectronic Technology TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA. | Electronic Components | Director/Board Member | |
NVasc, Inc.
NVasc, Inc. Medical SpecialtiesHealth Technology NVasc, Inc. is an early-stage ophthalmology company founded in February 2019 and funded by Kairos Ventures in November 2019. The company is based in Atherton, CA. The company is focused on treating the leading causes of blindness through choroidal and retinal revascularization. The company is planning to manufacture NVB001 that can be used in toxicokinetic studies and in early clinical trials in humans. NVasc has acquired the research rights to growth factors (NVB001 and NVB002) that have been shown to encourage the growth of non-leaking new vessels in the retina and choroid in mouse models of ischemic eye diseases. | Medical Specialties | Director/Board Member | |
Retina Global | Director/Board Member | ||
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Opus Genetics, Inc. is a gene therapy company that focuses on treating inherited retinal diseases. The company is based in Raleigh, NC, and leverages knowledge of the best science and the expertise of pioneers in ocular gene therapy to transparently drive transformative treatments to patients. The company has a unique model and purpose, and is backed by Foundation Fighting Blindness's venture arm, the RD Fund. Opus Genetics has wholly owned programs in numerous orphan retinal diseases, and its AAV-based gene therapy portfolio tackles some of the most neglected forms of inherited blindness while creating novel orphan manufacturing scale and efficiencies. The company was founded in 2021 by Benjamin R. Yerxa, Peter L. Ginsberg, Jason D. Menzo, Jean Bennett, Russell Kelley, Jean Bennett. Benjamin R. Yerxa has been the CEO since 2021. | Biotechnology | Director/Board Member | |
Corium LLC
Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Biotechnology | Chief Executive Officer | |
KeepYourSight Foundation
KeepYourSight Foundation Investment Trusts/Mutual FundsMiscellaneous KeepYourSight Foundation provides e-health initiative in the fight against blindness. The company is headquartered in united States. | Investment Trusts/Mutual Funds | Director/Board Member | |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Miscellaneous Commercial Services | Sales & Marketing |
Statistiques
Internationale
Etats-Unis | 46 |
France | 2 |
Belgique | 2 |
Allemagne | 2 |
Canada | 2 |
Sectorielle
Health Technology | 23 |
Consumer Services | 12 |
Commercial Services | 4 |
Electronic Technology | 3 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 57 |
Corporate Officer/Principal | 25 |
Founder | 19 |
Independent Dir/Board Member | 17 |
President | 16 |
Relations les plus connectées
Insiders | |
---|---|
Adrienne Graves | 38 |
Mark Baum | 36 |
Lauren Silvernail | 14 |
Andrew Boll | 10 |
Mark Mannebach | 9 |
Perry Sternberg | 8 |
John Saharek | 6 |
Kim Barratt | 5 |
Marty Makary | 4 |
Dennis E. Saadeh | 3 |
- Bourse
- Insiders
- Jamie Webb
- Connexions Sociétés